LUPUS ERYTHEMATOSUS
1931; American Medical Association; Volume: 23; Issue: 5 Linguagem: Inglês
10.1001/archderm.1931.03880230050006
ISSN2376-3760
Autores Tópico(s)Historical Medical Research and Treatments
ResumoFollowing Schamberg's introduction of gold sodium thiosulphate in the treatment for lupus erythematosus, several reports appeared on the use of this and similar compounds. For three years these drugs have been widely employed, and it now seems that an attempt to appraise their value in the light of a longer experience would be worth while. The use of gold compounds in the treatment of patients with lupus erythematosus dates from 1913, when Reute 1 first reported the use of gold potassium cyanide in a case lupus erythematosus. From that time until almost ten years later, little was written on this type of therapy, although in 1917 Adolf Feldt 2 had prepared a new gold compound, 4-amino-2-aurothiophenol carbonic acid, and had been using it with considerable success in the treatment for various types of systemic tuberculosis. In 1921, Kohrs 3 reported a case of lupus erythematosus with cure by this drug,
Referência(s)